| Revenue growth | 24.90% YoY for Q1 FY27. |
|---|---|
| Margins | EBITDA margin at 18.78%; focusing on higher-margin Pharma and IML. |
| Demand visibility | Strong momentum in Pharma and FMCG segments. |
| Management confidence | High; citing resilient supply chain and innovation-led growth. |
Growth
Revenue rose to ₹300.45cr (+24.9% YoY); EBITDA at ₹56.43cr (+19.11% YoY); Volume grew 6.25% to 12,089 MT.
Outlook
Pharma segment targeting 40% growth; expansion into Panipat, Cheyyar, Daman, and Satara. Consolidating Hyderabad units for EBITDA expansion.
Risks
Raw material price volatility and global supply chain disruptions mentioned as historical hurdles successfully managed.
Last quarter's promises, checked
Delivered
- Pharma target 50% growth (FY27) → delivered 39% (= BEAT)
- Consolidate 5 units to 2 → delivered 2 (= BEAT)
- Value growth 13-15% → delivered 24.9% (= BEAT)
Partly delivered
- EBITDA/kg target 42-43 → delivered 18.78% margin (~46/kg) (= BEAT)
Missed
- Volume growth 10-13% → delivered 6.25% (= MISS)
Investor Presentation filed with NSE, NSE: MOLDTKPAC. Summary written with AI assistance from the document.
Mold-Tek Packaging Ltd: key numbers
- Share price
- ₹669.85
- Market cap
- ₹2,226 Cr
- Revenue (annual)
- ₹886.6 Cr
- Net profit (annual)
- ₹72.87 Cr
- P/E (TTM)
- 29.3×Sector 41.4×
- Promoter holding
- 33.21%+0.02% QoQ
- FII holding
- 8.30%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mold-Tek Packaging Ltd
All →Mold-Tek Packaging Credit Rating
ICRA has reaffirmed the credit ratings for Mold-Tek Packaging Limited's bank facilities. The long-term facilities are rated [ICRA] A+(Positive) and short-term facilities [ICRA] A1.
Mold-Tek Packaging Annual General Meeting
Mold-Tek Packaging Limited held its 29th Annual General Meeting on September 21, 2026. The meeting transacted ordinary and special business, including dividend declaration and bonus shares.
Mold-Tek Packaging Earnings Call Transcript: Key Takeaways
Mold-Tek delivered record Q1 FY27 revenue exceeding 300 crores, driven by high-margin pharma and food segments. EBITDA/kg hit a record 46.7 despite volume headwinds in lubricants.
- Call
- Guides 10% growth
Mold-Tek Packaging Q1 FY27 Results: Net Profit ₹25.6 Cr, Up 14.3% YoY
Mold-Tek Packaging Ltd reported revenue from operations of ₹300.5 Cr (+24.9% YoY) and net profit of ₹25.6 Cr (+14.3% YoY) for Q1 FY27.
- Key figure
- Net profit ₹25.6 Cr · +14.3% YoY
Mold-Tek Packaging Earnings Call: Key Takeaways
Mold-Tek Packaging Q4 FY26 earnings transcript highlights a healthy 13.4% sales growth driven by strong performance in Pharma (+200% for full year) and Food/FMCG segments.
Mold-Tek Packaging Earnings Call: Key Takeaways
Mold-Tek Packaging is diversifying into pharma and food packaging while navigating stagnant lubricant segment performance through consolidation and margin expansion.